Table 4.
Bivariate analysis of SLE patient characteristics and attitudes by CYC treatment preferencea variables
| Characteristic | Unwilling to receive CYC | Willing to receive CYC | P-valueb |
|---|---|---|---|
| Number of subjects, n | 39 | 108 | |
| Race/ethnicity, n (%) | 0.02 | ||
| African-American | 31 (33.0) | 63 (67.0) | |
| White | 8 (15.1) | 45 (84.9) | |
| Medical insurance, n (%) | 0.03 | ||
| Without private | 24 (35.3) | 44 (64.7) | |
| With private | 15 (19.0) | 64 (81.0) | |
| Marital status, n (%) | 0.01 | ||
| Married | 11 (16.4) | 56 (83.6) | |
| Other (single, divorced, widowed) | 28 (35.0) | 52 (65.0) | |
| Perception of effectiveness, mean (s.d.) | 17.44 (3.79) | 22.12 (3.82) | <0.001 |
| Perception of risk, mean (s.d.) | 11.72 (2.33) | 10.92 (2.10) | 0.05 |
| Trust in physicians, mean (s.d.) | 35.79 (9.15) | 39.08 (7.64) | 0.03 |
aAmong patients with no history of taking CYC. bSignificance level of the χ2 (or Fisher’s exact) statistic for categorical variables and two-tailed t-test (or Wilcoxon’s rank sum test) for continuous variables.